Efficacy and safety of interleukin-17A inhibitors in patients with ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials

To assess the efficacy and safety of interleukin (IL)-17A inhibitors in patients with ankylosing spondylitis (AS). PubMed, EMBASE, and Web of Science were searched up to 5 February 2020 for randomized controlled trials (RCTs) that assessed the efficacy and safety of IL-17A inhibitors in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Peng, Zhang, Shuo, Hu, Binwu, Liu, Weijian, Lv, Xiao, Chen, Songfeng, Shao, Zengwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289786/
https://www.ncbi.nlm.nih.gov/pubmed/33432451
http://dx.doi.org/10.1007/s10067-020-05545-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289786/
https://www.ncbi.nlm.nih.gov/pubmed/33432451
http://dx.doi.org/10.1007/s10067-020-05545-y

Ejemplares similares